United States · Growth startup
7 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$248Mraised across 7 rounds since 2007, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
Reported by finsmes.comSEC filing: $13M sold, first sale Jun 2012
From a historical funding recordSEC filing: $13M sold, first sale Jun 2012
Reported by fiercebiotech.comSEC filing: $37M sold, first sale Oct 2010
Reported by deals.venturebeat.com
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
5AM Ventures
New Leaf Venture Partners
Clarus VenturesVatera Healthcare Partners
Nektar TherapeuticsFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Pearl Therapeutics's investors include 5AM Ventures, New Leaf Venture Partners, Clarus Ventures, Vatera Healthcare Partners and Nektar Therapeutics.
Pearl Therapeutics has raised $248M across 7 rounds since 2007.
Pearl Therapeutics's most recent round was a Growth of $42M in Apr 2013.
Pearl Therapeutics's largest round on record is $69M (Series C), in Oct 2010.
Pearl Therapeutics's first round on record, in Sept 2007, was backed by 5AM Ventures, New Leaf Venture Partners and Clarus Ventures.
Pearl Therapeutics's latest named round is a Growth, in Apr 2013.
Pearl Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·